Skip to main content
SpringerLink
Log in

Articular and ocular complications of inflammatory bowel disease

  • Chapter
Inflammatory Bowel Disease: From Bench to Bedside

  • 1268 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bywaters E, Ansell B. Arthritis associated with ulcerative colitis: a clinical and pathological study. Ann Rheum Dis 1958; 17: 169–83.

    PubMed  CAS  Google Scholar 

  2. Edwards F, Truelove S. The course and prognosis of ulcerative colitis. III. Complications. Gut 1964; 5: 1–15.

    PubMed  CAS  Google Scholar 

  3. Wright V, Watkinson G. The arthritis of ulcerative colitis. Br Med J 1965; 2: 670–5.

    PubMed  CAS  Google Scholar 

  4. Greenstein A, Janowitz H, Sachar D. Extra-intestinal complications of Crohn’s disease and ulcerative colitis. Medicine 1976; 55: 401–12.

    Article  PubMed  CAS  Google Scholar 

  5. Stein H, Volpin G, Shapira D, Suir E, Stevenberg A, Eidelman S. Musculoskeletal manifestations of Crohn’s disease. Bull Hosp Jt Dis 1993; 53: 17–20.

    PubMed  CAS  Google Scholar 

  6. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998; 42: 387–91.

    Article  PubMed  CAS  Google Scholar 

  7. van der Linden S, van der Heijde DM. Clinical and epidemiologic aspects of ankylosing spondylitis and spondyloarthropathies. Curr Opin Rheumatol 1996; 8: 269–74.

    Article  PubMed  Google Scholar 

  8. Calin A. Ankylosing spondylitis. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, eds. Oxford Textbook of Rheumatology. Oxford: Oxford University Press, 1998: 1058–70.

    Google Scholar 

  9. Dekker-Saeys B, Meuwissen S, VandenBerg-Loonen E, De Haas W, Agenant D, Tytgat G. Prevalence of peripheral arthritis, sacroiliitis and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis 1978; 37: 33–5.

    PubMed  CAS  Google Scholar 

  10. Wright V, Watkinson G. Sacroiliitis and ulcerative colitis. Br Med J 1965; 2: 675–80.

    PubMed  CAS  Google Scholar 

  11. Hollingsworth P, Cheah P, Dawkins R, Owen E, Calin A, Wood P. Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol 1983; 10: 247–54.

    PubMed  CAS  Google Scholar 

  12. McEniff N, Eustace S, McCarthy C, O’Malley M, Morain C, Hamilton S. Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography. Clin Imaging 1995; 19: 258–62.

    Article  PubMed  CAS  Google Scholar 

  13. Agnew JE, Pocock DG, Jewell DP. Sacroiliac joint uptake ratios in inflammatory bowel disease: relationship to back pain and to activity of bowel disease. Br J Radiol 1982; 55: 821.

    Article  PubMed  CAS  Google Scholar 

  14. Dougados M, Linden S, Juhlin R et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991; 34: 1218–27.

    Article  PubMed  CAS  Google Scholar 

  15. Brown MA, Pile KD, Kennedy LG et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996; 55: 268–70.

    PubMed  CAS  Google Scholar 

  16. Leirisalo-Repo M, Suoranta H. Ten year follow-up study of patients with Yersinia arthritis. Arthritis Rheum 1988; 31: 533–7.

    Article  PubMed  CAS  Google Scholar 

  17. Calin A, Fries JF. An ‘experimental’ epidemic of Reiter’s syndrome revisited. Follow-up evidence on genetic and environmental factors. Ann Intern Med 1976; 84: 564–6.

    PubMed  CAS  Google Scholar 

  18. Thomson GT, DeRubeis DA, Hodge MA, Rajanayagam C, Inman RD. Post-Salmonella reactive arthritis: late clinical sequelae in a point source cohort. Am J Med 1995; 98: 13–21.

    Article  PubMed  CAS  Google Scholar 

  19. Olivieri I, Salvarani C, Cantini F. Is Behçet’s disease part of the spondyloarthritis complex? [Editorial]. J Rheumatol 1997; 24: 1870–2.

    PubMed  CAS  Google Scholar 

  20. Dekker-Saeys B, Meuwissen S, Berg-Loonen EVD et al. Clinical characteristics and results of histocompatibitility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. Ann Rheum Dis 1978; 37: 36–41.

    Article  PubMed  CAS  Google Scholar 

  21. Brewerton D, Caffery M, Nicholls A, Walters D, James D. HL-A27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet 1974; 1: 956–8.

    Article  PubMed  CAS  Google Scholar 

  22. Mallas EG, Mackintosh P, Asquith P, Cooke WT. Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27). Gut 1976; 17: 906–10.

    PubMed  CAS  Google Scholar 

  23. Steer S, Jones H, Hibbert J, Gibson T, Sanderson J. CT defined sacroiliitis and HLA-B27 in Crohn’s disease. Gut 1999; 44(Suppl. 1.): A41.

    Google Scholar 

  24. Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000; 118: 274–8.

    Article  PubMed  CAS  Google Scholar 

  25. Ebringer A. Ankylosing spondylitis is caused by Klebsiella. Evidence from immunogenetic, microbiologic, and serologic studies. Rheum Dis Clin N Am 1992; 18: 105–21.

    CAS  Google Scholar 

  26. Gaston J, Life P, Granfors K et al. Synovial T lymphocyte recognition of organisms that trigger reactive arthritis. Clin Exp Immunol 1989; 76: 348–53.

    PubMed  CAS  Google Scholar 

  27. Hermann E, Fleischer B, Mayet WJ, Poralla T, Meyer zum Buschenfelde KH. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis. Clin Exp Immunol 1989; 75: 365–70.

    PubMed  CAS  Google Scholar 

  28. Hermann E, Yu D, zumBuschenfelde K, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993; 342: 646–50.

    Article  PubMed  CAS  Google Scholar 

  29. Rath H, Herfath H, Ikeda J et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis and arthritis in HLA-B27/Human β2 microglobulin transgenic rats. J Clin Inv 1996; 98: 945–53.

    CAS  Google Scholar 

  30. Taurog JD, Richardson JA, Croft JT et al. The germ-free state prevents development of gut and joint inflammation in HLA B27 transgenic rats. J Exp Med 1994; 180: 2359–64.

    Article  PubMed  CAS  Google Scholar 

  31. Rath H, Schulta M, Grenther W et al. Colitis, gastritis and antibacterial lmphocyte responses in HLA-B27 transgenic rats monoinnoculated with Bacteroides vulgatus or Escherichia coli. Gastroenterology 1997; 112: A1068 (Abstract).

    Google Scholar 

  32. Rath H, Ikeda J, Wilson K, Sartor R. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 1997; 112: A1068 (Abstract).

    Google Scholar 

  33. Orchard TR, Jewell DP. The importance of ileocaecal integrity in the arthritic complications of Crohn’s disease. Inflam Bowel Dis 1999; 5: 92–7.

    Article  CAS  Google Scholar 

  34. Bhagat S, Das KM. A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. Gastroenterology 1994; 107: 103–8.

    PubMed  CAS  Google Scholar 

  35. Van den Bosch F, Kruithof E, Baeten D, De Keyser F, Mielants H, Veys EM. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis 2000; 59: 428–33.

    Article  PubMed  Google Scholar 

  36. Brandt J, Haibel H, Comely D et al. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 2000; 43: 1346–52.

    Article  PubMed  CAS  Google Scholar 

  37. Van den Bosch F, Kruithof E, De Vos M, De Keyser F, Mielants H. Crohn’s disease associated with spondyloar thropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 2000; 356: 1821–2.

    Article  PubMed  Google Scholar 

  38. Maini RN, Breedveld FC, Kalden JR et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1552–63.

    Article  PubMed  CAS  Google Scholar 

  39. Orchard TR, Chua C, Cheng H, Jewell DP. Clinical features of erythema nodosum (EN) and uveitis associated with inflammatory bowel disease. Gastroenterology 2000; 118: 755.

    Article  Google Scholar 

  40. Das KM, Vecchi M, Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology 1990; 98: 464–9.

    PubMed  CAS  Google Scholar 

  41. Orchard TR, Dhar A, Simmons JD, Welsh KI, Jewell DP Phenotype determining genes in the HLA region may determine the presence of uveitis and erythema nodosum (EN) in inflammatory bowel disease. Gastroenterology 2000; 118: A4832.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St Mary’s Hospital, Praed Street, London, UK

    Timothy R. Orchard (Consultant Gastroenterology)

  2. University of Oxford, Oxford, UK

    Derek P. Jewell (Professor of Gastroenterology)

Authors
  1. Timothy R. Orchard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Derek P. Jewell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cedars-Sinai IBD Center, Los Angeles, CA, USA

    Stephan R. Targan  & Loren C. Karp  & 

  2. Cork University Hospital, Cork, Ireland

    Fergus Shanahan

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic Publishers

About this chapter

Cite this chapter

Orchard, T.R., Jewell, D.P. (2003). Articular and ocular complications of inflammatory bowel disease. In: Targan, S.R., Shanahan, F., Karp, L.C. (eds) Inflammatory Bowel Disease: From Bench to Bedside. Springer, Boston, MA. https://doi.org/10.1007/0-387-25808-6_39

Download citation

  • DOI: https://doi.org/10.1007/0-387-25808-6_39

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25807-2

  • Online ISBN: 978-0-387-25808-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation